Search research articles
Contact Us
Filters
Showing results (1-10 of 124) with videos related to
Page
of 13
Sort By:
Clinical Lung Cancer
|
January 21, 2004
The role of gemcitabine and paclitaxel as second-line chemotherapy for the treatment of advanced non small-cell lung cancer (NSCLC)
S Kakolyris, V Georgoulias
Journal of Theoretical Biology
|
May 22, 2017
Evaluation of artificial time series microarray data for dynamic gene regulatory network inference
P Xenitidis, I Seimenis, S Kakolyris, et al.
In Vivo (Athens, Greece)
|
January 1, 1995
Immunohistochemical detection of fibronectin in early and advanced atherosclerosis
S Kakolyris, P Karakitsos, M Tzardi, et al.
Cancer Investigation
|
October 30, 2013
H2AX a promising biomarker for lung cancer: a review
D Matthaios, P Hountis, P Karakitsos, et al.
Oncology
|
November 26, 2011
Molecular pathogenesis of pancreatic cancer and clinical perspectives
D Matthaios, P Zarogoulidis, I Balgouranidou, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 16, 1999
Concurrent twice-a-week docetaxel and radiotherapy: a dose escalation trial with immunological toxicity evaluation
M I Koukourakis, A Giatromanolaki, S Schiza, et al.
Leukemia
|
September 1, 1994
Characterization of interleukin 2 receptors on B-cell chronic lymphocytic leukemia cells
V Tsilivakos, A Tsapis, S Kakolyris, et al.
Hippokratia
|
August 13, 2013
Outcome of lung cancer patients admitted to the intensive care unit with acute respiratory failure
S Anisoglou, C Asteriou, N Barbetakis, et al.
Hippokratia
|
March 27, 2024
Prognostic significance of <i>SOX17</i> and <i>WNT5a</i> promoter methylation status in circulating cell-free DNA metastatic colorectal cancer patients
A Vagionas, I Balgkouranidou, T Koukaki, et al.
Medical Oncology (Northwood, London, England)
|
June 29, 2000
Phase I/II dose escalation study of docetaxel and carboplatin combination supported with amifostine and GM-CSF in patients with incomplete response following docetaxel chemo-radiotherapy: additional chemotherapy enhances regression of residual cancer
M I Koukourakis, A Giatromanolaki, S Kakolyris, et al.
Page
of 13
Search research articles
Search
Showing results (1-10 of 124) with videos related to
Sort By:
Page
of 13
Clinical Lung Cancer
|
January 21, 2004
The role of gemcitabine and paclitaxel as second-line chemotherapy for the treatment of advanced non small-cell lung cancer (NSCLC)
S Kakolyris, V Georgoulias
Journal of Theoretical Biology
|
May 22, 2017
Evaluation of artificial time series microarray data for dynamic gene regulatory network inference
P Xenitidis, I Seimenis, S Kakolyris, et al.
In Vivo (Athens, Greece)
|
January 1, 1995
Immunohistochemical detection of fibronectin in early and advanced atherosclerosis
S Kakolyris, P Karakitsos, M Tzardi, et al.
Cancer Investigation
|
October 30, 2013
H2AX a promising biomarker for lung cancer: a review
D Matthaios, P Hountis, P Karakitsos, et al.
Oncology
|
November 26, 2011
Molecular pathogenesis of pancreatic cancer and clinical perspectives
D Matthaios, P Zarogoulidis, I Balgouranidou, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 16, 1999
Concurrent twice-a-week docetaxel and radiotherapy: a dose escalation trial with immunological toxicity evaluation
M I Koukourakis, A Giatromanolaki, S Schiza, et al.
Leukemia
|
September 1, 1994
Characterization of interleukin 2 receptors on B-cell chronic lymphocytic leukemia cells
V Tsilivakos, A Tsapis, S Kakolyris, et al.
Hippokratia
|
August 13, 2013
Outcome of lung cancer patients admitted to the intensive care unit with acute respiratory failure
S Anisoglou, C Asteriou, N Barbetakis, et al.
Hippokratia
|
March 27, 2024
Prognostic significance of <i>SOX17</i> and <i>WNT5a</i> promoter methylation status in circulating cell-free DNA metastatic colorectal cancer patients
A Vagionas, I Balgkouranidou, T Koukaki, et al.
Medical Oncology (Northwood, London, England)
|
June 29, 2000
Phase I/II dose escalation study of docetaxel and carboplatin combination supported with amifostine and GM-CSF in patients with incomplete response following docetaxel chemo-radiotherapy: additional chemotherapy enhances regression of residual cancer
M I Koukourakis, A Giatromanolaki, S Kakolyris, et al.
Page
of 13